INSIGHTS ON ENTERPRISE SOLUTIONS
-
![The Editors’ Roundtable: A 2025 Retrospective Of The Life Science Industry]( "The Editors' Roundtable: A 2025 Retrospective Of The Life Science Industry")
The Editors' Roundtable: A 2025 Retrospective Of The Life Science IndustryIn this special edition of “Better Biopharma,” host Tyler Menichiello is joined by fellow chief editors from across the Life Science Connect ecosystem to reflect on the year and share their industry outlooks for 2026.
-
![From The Floor at cphi 2025]( "From The Floor At CPHI 2025: Takeaways Everyone Should Know")
From The Floor At CPHI 2025: Takeaways Everyone Should KnowGain insights into evolving pharma priorities, from supply chain resilience to advanced manufacturing, and why flexibility, scalability, and technical expertise matter in a dynamic global market.
-
![Bora Pharmaceuticals CDMO capabilities overview]( "CDMO Capabilities Overview")
CDMO Capabilities OverviewExplore global CDMO capabilities that streamline drug development and manufacturing, leveraging advanced infrastructure and regulatory expertise from early formulation through commercial production.
-
![Bora Corporate Overview 2025]( "Corporate Overview 2025: Business Strategy & Outlook")
Corporate Overview 2025: Business Strategy & OutlookExplore how a growing pharma organization uses innovation, regulatory expertise, and strategic partnerships to deliver targeted therapies and drive impact across the evolving healthcare landscape.
-
State-Of-The-Art CDMO Facility - Maple Grove12/22/2025
Discover how a U.S.-based CDMO combines advanced infrastructure, quality-driven processes, and flexible manufacturing to support pharmaceutical development and commercial supply.
-
The Impact Of PEGs In The Small Molecule API Market12/22/2025
Explore how PEG selection shapes drug development success by understanding the benefits of expert CDMO partnerships that deliver custom solutions to enhance your small molecule program.
-
Periodic Counter Current Chromatography: A Step Toward Continuous DSP12/19/2025
PCC boosts Protein A capture efficiency, cuts resin costs, increases productivity, and enables continuous downstream processing without sacrificing quality or compliance.
-
Enriching Sterile Fill/Finish Services With A Patient-Centric Approach12/18/2025
Through early collaboration and advanced aseptic technology, organizations can overcome complex formulation challenges to ensure safe, effective treatments reach patients more efficiently than before.
ENTERPRISE SOLUTIONS
-
![GettyImages-506999858-scientists-cell-culture-lab-development]( "Viral Clearance Testing For Biologics, Vaccines & AAV Therapies")
Viral clearance protects patients by validating virus removal and inactivation in biologics manufacturing, meeting global standards through rigorous, audit-ready studies and expert oversight.
-
![Asahi Kasei - VANTIJ]( "VANTIJ® Single-Use Virus Filtration Controller")
Automating critical filtration steps significantly reduces cross-contamination risks and operational costs. This single-use approach ensures process repeatability and eliminates cleaning downtime.
-
![GettyImages-1351826681-capping-vials-fill-finish]( "Aseptic Manufacturing: Fill/Finish For Vials, Syringes, Cartridges")
Sterile fill/finish requires isolator technology and regulatory compliance. From clinical development to commercial scale, technical expertise ensures the integrity of liquid and lyophilized injectables.
-
![GettyImages-2154728338 global]( "Minaris Advanced Therapies Overview")
Global cell and gene therapy CDMO providing GMP manufacturing, testing, and development services with commercial success, regulatory expertise, and advanced multi‑modality capabilities.
-
![GettyImages-1331874048 MSC, stem cells]( "Cell Therapy Lot Release Package")
Comprehensive cGMP-compliant cell therapy lot release testing includes identity, potency, safety, and characterization assays, ensuring regulatory compliance and timely product release for advanced therapies.
